GOLDMAN SACHS GROUP INC - SPDR SER TR ownership

SPDR SER TR's ticker is SPIB and the CUSIP is 78464A375. A total of 403 filers reported holding SPDR SER TR in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SPDR SER TR
ValueSharesWeighting
Q2 2023$570,819
-66.1%
17,777
-66.9%
0.00%
Q3 2022$1,682,000
-92.1%
53,715
-91.4%
0.00%
-100.0%
Q1 2022$21,322,000
+771.7%
624,366
+825.3%
0.00%
+300.0%
Q1 2021$2,446,000
+15.7%
67,476
+18.7%
0.00%0.0%
Q4 2020$2,114,000
+66.5%
56,866
+64.5%
0.00%
Q3 2020$1,270,000
+43.0%
34,559
+42.2%
0.00%
Q2 2020$888,000
+199.0%
24,311
+178.4%
0.00%
Q1 2020$297,000
-92.7%
8,733
-92.4%
0.00%
-100.0%
Q4 2019$4,049,000
-70.9%
114,682
-70.9%
0.00%
-75.0%
Q3 2019$13,896,000
-14.7%
393,883
-15.6%
0.00%
-20.0%
Q2 2019$16,294,000
+325.9%
466,490
+316.7%
0.01%
+400.0%
Q1 2019$3,826,000
+310.5%
111,957
+296.8%
0.00%
Q4 2018$932,000
-76.0%
28,215
-75.8%
0.00%
-100.0%
Q3 2018$3,882,000
+82.3%
116,572
+82.2%
0.00%0.0%
Q2 2018$2,130,000
+783.8%
63,981
+791.5%
0.00%
Q1 2018$241,000
-93.6%
7,177
-93.4%
0.00%
-100.0%
Q4 2017$3,743,000
-15.0%
109,384
-14.3%
0.00%0.0%
Q3 2017$4,406,000
-11.2%
127,663
-11.5%
0.00%0.0%
Q2 2017$4,964,000
-32.4%
144,267
-31.5%
0.00%
-50.0%
Q2 2016$7,343,000
-76.7%
210,456
-77.1%
0.00%
-80.0%
Q1 2016$31,506,000919,3530.01%
Other shareholders
SPDR SER TR shareholders Q3 2023
NameSharesValueWeighting ↓
INTEGRATED CAPITAL MANAGEMENT, INC. 312,958$9,842,5148.70%
Astoria Portfolio Advisors LLC. 562,521$17,528,1648.46%
ERTS Wealth Advisors, LLC 1,106,393$34,796,0708.38%
Buckingham Capital Management, Inc. 1,736,209$54,603,7748.32%
Flagstone Financial Management 577,959$18,176,8188.31%
Burt Wealth Advisors 699,832$22,009,7166.76%
Cherry Tree Wealth Management, LLC 710,795$22,354,5146.55%
FIDELITY D & D BANCORP INC 172,353$5,420,5025.57%
Hofer & Associates. Inc 164,719$5,180,4025.31%
Leicht Financial Planning & Wealth Management, Inc. 270,111$8,495,0075.24%
View complete list of SPDR SER TR shareholders